[CRVS] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
19-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -10.88%
YoY- 58.93%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 246 0 0 0 -
PBT -40,217 -4,262 -5,701 -6,653 -6,000 -6,503 -7,873 195.72%
Tax 0 0 -20 -95 -425 -403 923 -
NP -40,217 -4,262 -5,701 -6,653 -6,000 -6,503 -8,796 174.71%
Tax Rate - - - - - - - -
Total Cost 40,217 4,262 5,701 6,899 6,000 6,503 8,796 174.71%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -2,704.47 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.60 -0.07 -0.12 -0.14 -0.12 -0.14 -0.19 114.79%
EPS Diluted -0.60 -0.07 -0.12 -0.14 -0.12 -0.14 -0.19 114.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.